HSBC Holdings
TERN

HSBC Holdings’s Terns Pharmaceuticals TERN Stock Holding History

HSBC Holdings’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,515
Closed -$66.4K – 3237
2025
Q1 		$66.4K Sell
23,515
-12,383
-34% -$50.6K ﹤0.01% 2874
2024
Q4 		$195K Buy
35,898
+24,542
+216% +$166K ﹤0.01% 2727
2024
Q3 		$95K Buy
11,356
+1,199
+12% +$9.87K ﹤0.01% 2807
2024
Q2 		$70.8K Sell
10,157
-3,815
-27% -$23.1K ﹤0.01% 2788
2024
Q1 		$91.7K Buy
+13,972
New +$91.2K ﹤0.01% 2860

Other funds holding TERN

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

HSBC Holdings's TERN Position: Q2 2025 in Review

HSBC Holdings sold out of Terns Pharmaceuticals (TERN) in Q2 2025, closing a stake of 23,515 shares — an estimated $66.4K sold.

HSBC Holdings first reported a position in TERN in Q1 2024 and held it in 5 quarters. The position peaked at $195K in Q4 2024. 129 funds tracked by Wall St. Rank hold TERN as of Q2 2025.

  • HSBC Holdings reported no remaining Terns Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 23,515 Terns Pharmaceuticals shares in Q2 2025, an estimated $66.4K.
  • HSBC Holdings first reported a position in Terns Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • HSBC Holdings's Terns Pharmaceuticals position peaked at $195K in Q4 2024.
  • 129 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.